Homocysteine and ischemic stroke subtype: A relationship study in Chinese patients

Neurological Research

Volumn 32, Issue 6, 2010, Pages 636-641

  Wang, Yongjun ^a   Ma, Yuetao ^a   Zhao, Xingquan ^a   Zhang, Wei ^a   Liu, Liping ^a   Wang, Yilong ^a   Fang, Ruile ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

HOMOCYSTEINE; STROKE SUBTYPES; TOAST

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CHINESE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; ANALYSIS OF VARIANCE; BLOOD; CHINA; CLASSIFICATION; COMPLICATION; EPIDEMIOLOGY; ETHNOLOGY; FLUORESCENCE POLARIZATION IMMUNOASSAY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; STROKE;

AGED; ANALYSIS OF VARIANCE; BRAIN ISCHEMIA; CHINA; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HOMOCYSTEINE; HUMANS; LEUKOARAIOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 77953829432     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164109X12445616596445     Document Type: Article

References (34)

1. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128
2. Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Ann Intern Med 1999; 131: 352-355 (Pubitemid 29424629)
3. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-1398
4. Hankey GJ, Eikelboom JW. Homocysteine and stroke. Curr Opin Neurol 2001; 14: 95-102
5. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: From basic science to clinical evidence. Thromb Haemost 2005; 94: 907-915
6. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004; 11 (Suppl. 1): S56-S64
7. Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocyst(e)ine and ischaemic stroke due to large- and smallartery disease but not other etiological subtypes of ischaemic stroke. Stroke 2000; 31: 1069-1075
8. Parnetti L, Caso V, Santucci A, et al. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci 2004; 25: 13-17
9. Bushnell CD, Goldstein LB. Homocysteine testing in patients with acute ischemic stroke. Neurology 2002; 59: 1541-1546
10. Khan U, Crossley C, Kalra L, et al. Homocysteine and Its Relationship to Stroke Subtypes in a UK Black Population: The South London Ethnicity and Stroke Study. Stroke 2008; 39: 2943-2949
11. Caplan LR. Intracranial large artery occlusive disease. Curr Neurol Neurosci Rep 2008; 8: 177-181
12. Tan NC, Venketasubramanian N, Saw SM, et al. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults. Stroke 2002; 33: 1956-1962
13. Jiménez I, Agulla J, Pouso M, et al. Cognitive impairment associated to leukoaraiosis: Its pathophysiology, clinical manifestations and treatment. Rev Neurol 2008; 47: 536-544
14. Helenius J, Tatlisumak T. Treatment of leukoaraiosis: A futuristic view. Curr Drug Targets 2007; 8: 839-845
15. Liu L. Cardiovascular diseases in China. Biochem Cell Biol 2007; 85: 157-163
16. Adams HP, Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41
17. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-1689
18. Chao CL, Kuo TL, Lee YT. Effects of methionine-induced hyperhomocysteinaemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 2000; 101: 485-490
19. Sacco RL, Anand K, Lee HS, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: The Northern Manhattan Study. Stroke 2004; 35: 2263-2269
20. Rohde LE, Hennekens CH, Ridker PM. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 1999; 19: 1595-1599
21. Hassan A, Hunt BJ, O'Sullivan M, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212-219
22. Dardik R, Varon D, Tamarin I, et al. Homocysteine and oxidized low density lipoprotein enhances platelet adhesion to endothelial cells under flow conditions: Distinct mechanisms of thrombogenic modulation. Thromb Haemost 2000; 83: 338-344
23. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. Br Med J 2002; 325: 1202
24. Perini F, Galloni E, Bolgan I, et al. Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: Stronger association with small artery disease. Neurol Sci 2005; 26: 310-318
25. Shimizu H, Kiyohara Y, Kato I, et al. Plasma homocyst(e)ine concentrations and the risk of subtypes of cerebral infarction. The Hisayama study. Cerebrovasc Dis 2002; 13: 9-15
26. Markus HS. Genes, endothelial function and cerebral small vessel disease in man. Exp Physiol 2008; 93: 121-127
27. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 1968; 12: 1-15
28. Fisher CM. Lacunar infarcts: A review. Cerebrovasc Dis 1991; 1: 311-320
29. Hassan A, Hunt B, O'Sullivan M, et al. The role of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126: 424-432
30. Markus HS, Hunt B, Palmer K, et al. Markers of endothelial and haemostatic activation and progression of cerebral white matter hyperintensities: Longitudinal results of the Austrian Stroke Prevention Study. Stroke 2005; 36: 1410-1414
31. Fassbender K, Mielke O, Bertsch T, et al. Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999; 353: 1586-1587
32. Naka H, Nomura E, Takahashi T, et al. Plasma total homocysteine levels are associated with advanced leukoaraiosis but not with asymptomatic microbleeds on T2*-weighted MRI in patients with stroke. Eur J Neurol 2006; 13: 261-265
33. Lindgren A, Brattstrom L, Norrving B, et al. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 1995; 26: 795-800
34. Vermeulen EG, Stehouwer CD, Twisk JW, et al. Effect of homocysteinelowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial. Lancet 2000; 355: 517-522